Coronary Intervention in Patients With Acute Coronary Syndrome: Does Every Culprit Lesion Require Revascularization?
- Sripal BangaloreAffiliated withDivision of Cardiology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School
- , David P. FaxonAffiliated withDivision of Cardiology, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School Email author
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
In patients presenting with acute coronary syndromes, 30–60% of patients have multiple significant coronary lesions. Patients presenting with acute coronary syndrome and multivessel disease have a significant increase in the incidence of major cardiovascular morbidity and mortality when compared with patients who have single-vessel disease. Although great progress has been made to reduce the extent of infarction through effective and rapid reperfusion due to faster time to reperfusion, potent antiplatelets, and antithrombotics, there is not much consensus as to how best to treat multivessel disease in patients presenting with acute coronary syndromes. We present a review of the current body of evidence for safety and efficacy of multivessel revascularization in patients presenting with acute coronary syndromes.
KeywordsCulprit lesion angioplasty Acute coronary syndromes Complete revascularization
- Coronary Intervention in Patients With Acute Coronary Syndrome: Does Every Culprit Lesion Require Revascularization?
Current Cardiology Reports
Volume 12, Issue 4 , pp 330-337
- Cover Date
- Print ISSN
- Online ISSN
- Current Science Inc.
- Additional Links
- Culprit lesion angioplasty
- Acute coronary syndromes
- Complete revascularization
- Industry Sectors